Total Funding
70
64
Total FundingSeries E raised
Growth Score 70 in past quarter
-12 pts
Heat Score 64 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
14139
Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.
Andrew L. Pecora: FounderPast Role: Progenitor Cell Therapy, Co-Founder, Chairman and Chief Executive
Mike Doyle: President and CEOPast Role: QPID Health, President & CEO
Verana Health
About the Company
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.
